Enanta Pharmaceuticals, Inc.
Enanta Pharmaceuticals, Inc. (ENTA) SEC Filings & 10-K Annual Reports
SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.
SEC EDGAR · data.sec.gov · CIK 0001177648 · ENTA · NASDAQ · as of Jun 8, 2026
Filing snapshot
Source: SEC EDGAR (data.sec.gov) · CIK 0001177648 · Updated hourly · Not investment advice
Latest Annual Report
Latest Key Filings
Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.
SEC Filing History
About SEC Filings & 10-K Annual Reports
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) has submitted 823 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2013. As a Healthcare sector company with CIK 0001177648, all filings are publicly accessible via the EDGAR database at no cost.
The annual 10-K report is Enanta Pharmaceuticals, Inc.'s most comprehensive regulatory disclosure. The most recent Enanta Pharmaceuticals, Inc. 10-K was filed on 2025-11-19 for fiscal year ending 2025. Historical ENTA 10-K annual reports are available from 2002 through 2025.
Investors researching Enanta Pharmaceuticals, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.
Frequently Asked Questions
ENTA SEC Filings · 8 questionsEnanta Pharmaceuticals, Inc. (ENTA) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 823 filings and access original documents at no cost. Enanta Pharmaceuticals, Inc.'s CIK is 0001177648.